After being diagnosed with a rare and deadly form of malignant melanoma - acral lentiginous melanoma - Dr George McGavin embarks on a highly emotional and deeply personal journey as he goes through treatment for his cancer. George’s treatment is targeted drug therapy, using drugs approved for use by the NHS only weeks before his diagnosis. During this journey, he is given unprecedented access to the process and science behind his medical treatment and diagnosis. He also meets some of the most highly regarded scientists in the field of cancer research in his quest to understand not just his disease but what the future holds as a whole for cancer treatment. Amongst them are Professor Sir Michael Stratton, director of the Wellcome Sanger Institute and chief executive officer of the Wellcome Genome Campus, whose work resulted in the discovery of the mutation in the B RAF gene responsible for his form of melanoma. George also travels to Houston, Texas to meet Professor James P Allison, winner of the 2018 Nobel Prize in Medicine, to find out about his pioneering work in the field of immunotherapy - the greatest breakthrough in cancer research in a century. Back home in his own hospital, he meets a unique group of stage four melanoma patients who owe their lives to Professor Allison’s work. Ultimately, his journey culminates when he receives his prognosis, after three months of treatment, which will determine his future. Will these groundbreaking drugs actually work?
What's worse for us: sugar or fat? To answer the hottest question in nutrition, twin doctors Chris and Xand Van Tulleken go on month-long high-fat and high-sugar diets. The effects on their bodies are shocking and surprising. But they also discover that in the debate about fat and sugar, the real enemy might have been hiding in plain sight.
At an extraordinary moment in the history of one of the world’s oldest and most controversial drugs, Horizon investigates the very latest medical and scientific research into the effects of cannabis on the brain and the body. Medicinal cannabis became legal in the UK on 1 November 2018, but it is still shrouded in controversy. A&E doctor Javid Abdelmoneim wants to find out whether it will help or harm patients. Javid meets the young epilepsy patient responsible for changing the law around medicinal cannabis in the UK and sees the remarkable effects it has on his condition. He visits a medicinal cannabis farm in Denmark to learn how a company known for growing the recreational drug are now producing medicinal cannabis to be exported all over Europe. He travels to Israel, to find out why they have been using cannabis as a medicine for over 20 years and meets the scientists studying the safety and effectiveness of cannabis in treating pain. And he meets the so-called godfather of cannabis, who at 88 years old is still an active research scientist and considered the world’s leading cannabis expert. In the UK Javid encounters the first British patient to be prescribed intoxicating herbal cannabis to treat her chronic condition. He meets psychiatrists at King’s College London who reveal their new study linking cannabis more strongly than ever to alarming mental health problems. And he takes part in a groundbreaking trial looking at the effects of the different chemicals in cannabis on the brain.
With more research being done into the link between what we eat and how we feel, the health-food industry is booming, and so-called superfoods are leading the way. Many people admit to buying such products because they believe they make them feel significantly better - but is this true? Jonathan Maitland investigates whether superfood claims are fact or fiction
Nearly one-third of adults engage in problem drinking at some point in their lives. Health professionals assess drinkers at risk on a spectrum ranging from low-risk to an alcohol use disorder that can range from mild to severe. Risky Drinking challenges viewers to recognize when their drinking may be putting them at risk and offers information that could help millions of people lead healthier lives. Through case studies and expert analysis, the film investigates the broad spectrum of risky drinking at different ages and stages in people’s lives,
2017 • Health